A cross-sectional, diurnal, and follow-up study of platelet activation and endothelial dysfunction in malignant phase hypertension

American Journal of Hypertension

Volumn 14, Issue 8 I, 2001, Pages 823-828

  Lip, Gregory Y H ^a   Edmunds, Eiry ^a   Hee, Foo Leong Li Saw ^a   Blann, Andrew D ^a   Beevers, D Gareth ^a  

^a UNIVERSITY DEPARTMENT OF MEDICINE   (United Kingdom)

Author keywords

Fibrinogen; Malignant hypertension; Soluble P selectin; Von Willebrand factor (vWf)

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FIBRINOGEN; PADGEM PROTEIN; VON WILLEBRAND FACTOR;

ADULT; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE REGULATION; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; MALE; MALIGNANT HYPERTENSION; PRIORITY JOURNAL; THROMBOCYTE ACTIVATION; THROMBOGENESIS; VASCULAR ENDOTHELIUM;

ADULT; AGED; ANTIHYPERTENSIVE AGENTS; CIRCADIAN RHYTHM; COHORT STUDIES; CROSS-SECTIONAL STUDIES; ENDOTHELIUM, VASCULAR; FEMALE; FIBRINOGEN; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION, MALIGNANT; MALE; MIDDLE AGED; P-SELECTIN; PLATELET ACTIVATION; SOLUBILITY; VON WILLEBRAND FACTOR;

EID: 0034919694     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-7061(01)02045-3     Document Type: Article

References (23)

1. The role of rheology and haemostatic factors in hypertension
2. Prothrombotic factors, endothelial function and left ventricular hypertrophy in isolated systolic hypertension compared with systolic-diastolic hypertension
3. Von Willebrand factor and soluble E-selectin in hypertension: Influence of treatment and value in predicting the progression of atherosclerosis
4. Relation of endothelium, thrombogenesis and haemorheology in systemic hypertension to ethnicity and left ventricular hypertrophy
5. Some different types of essential hypertension, their course and prognosis
6. Hypertension - Treated and untreated: A study of 400 cases
7. Complications and survival of 315 patients with malignant-phase hypertension
8. The survival of malignant hypertension in blacks, whites and Asians in Britain
9. Retinal changes in malignant hypertension
10. Lack of difference between malignant and accelerated hypertension
11. Malignant hypertension. Improving prognosis in a rare disease
12. Abnormal haemostasis and blood viscosity in malignant hypertension
13. Progressive vascular damage in hypertension is associated with increased levels of circulating P-selectin
14. Von Willebrand factor antigen and fibronectin in essential hypertension
15. Factor VII hyperactivity and endothelial damage are found in elderely hypertensives only when concomitant with microalbuminuria
16. Haemostasis balance disorders in patients with essential hypertension
17. Clustering of endothelial markers of vascular damage in human slat-sensitive hypertension
18. Evidence of platelet activation in hypertension
19. Relationship of fibrinogen levels and hemostatic abnormalities with organ damage in hypertension
20. Abnormalities of coagulation and the development of malignant phase hypertension
21. Circadian variation in platelet function in healthy volunteers
22. Circadian variation of endothelial cell function, red blood cell deformability and dehydro-thromboxane B2 in healthy volunteers
23. Platelet hyperactivity in hypertensive older patients is controlled by lowering blood pressure